Review of psychotherapeutic interventions on depression in cancer patients and their impact on disease progression

References

• Aizer, A.A., Chen, M.H., McCarthy, E.P., Mendu, M.L. Koo, S., Wilhite, T.J., Graham, P.L., Choueiri, T.K., Hoffman, K.E., Martin, N.E., Hu, J.C. & Nguyen, P.L. (2013). Cancer survival and matrimony: A marriage made in heaven. Journal of Clinical Oncology, 31, 3869–3876.
   PubMed Web of Science ®Google Scholar
• Akechi, T., Nakano, T., Okamura, H., Ueda, S., Akizuki, N., Nakanishi, T., … Uchitomi, Y. (2001). Psychiatric disorders in cancer patients: Descriptive analysis of 1721 psychiatric referrals at two Japanese cancer center hospitals. Japanese Journal of Clinical Oncology, 31, 188–194.
   PubMed Web of Science ®Google Scholar
• Akechi, T., Okuyama, T., Onishi, J., Morita, T. & Furukawa, T.A. (2008). Psychotherapy for depression among incurable cancer patients. Cochrane Database of Systematic Reviews, 2, CD005537.
   Google Scholar
• Andersen, B.L., Thornton, L.M., Shapiro, C.L., Farrar, W.B., Mundy, B.L., Yang, H.C. & Carson, W.E. III. (2010). Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants. Clinical Cancer Research, 16, 3270–3278.
   PubMed Web of Science ®Google Scholar
• Andersen, B.L., Yang, H.C., Farrar, W.B., Golden-Kreutz, D.M., Emery, C.F., Thornton, L.M., … Carson, W.E. III. (2008). Psychologic intervention improves survival for breast cancer patients: A randomized clinical trial. Cancer, 113, 3450–3458.
   PubMed Web of Science ®Google Scholar
• Antonova, L. & Mueller, C.R. (2008). Hydrocortisone down-regulates the tumor suppressor gene BRCA1 in mammary cells: A possible molecular link between stress and breast cancer. Genes Chromosomes Cancer, 47, 341–352.
   PubMedGoogle Scholar
• Barron, T.I., Connolly, R.M., Sharp, L., Bennett, K. & Visvanathan, K. (2011). Beta blockers and breast cancer mortality: A population-based study. Journal of Clinical Oncology, 29, 2635–2644.
   PubMed Web of Science ®Google Scholar
• Beaudreau, S.A., Kaci Fairchild, J., Spira, A.P., Lazzeroni, L.C. & O’Hara, R. (2012). Neuropsychiatric symptoms, apolipoprotein E gene, and risk of progression to cognitive impairment, no dementia and dementia: The Aging, Demographics, and Memory Study (ADAMS). International Journal of Geriatric Psychiatry, 28, 672–680.
   PubMedGoogle Scholar
• Ben-Eliyahu, S., Page, G.G., Yirmiya, R. & Shakhar, G. (1999). Evidence that stress and surgical interventions promote tumor development by suppressing natural killer cell activity. International Journal of Cancer, 80, 880–888.
   PubMed Web of Science ®Google Scholar
• Ben-Eliyahu, S., Yirmiya, R., Liebeskind, J.C., Taylor, A.N. & Gale, R.P. (1991). Stress increases metastatic spread of a mammary tumor in rats: Evidence for mediation by the immune system. Brain Behavior and Immunity, 5, 193–205.
   PubMedGoogle Scholar
• Berntson, G.G., Bigger, J.T. Jr, Eckberg, D.L., Grossman, P., Kaufmann, P.G., Malik, M., … van der Molen, M.W. (1997). Heart rate variability: Origins, methods, and interpretive caveats. Psychophysiology, 34, 623–648.
   PubMed Web of Science ®Google Scholar
• Blackburn, E.H. & Collins, K. (2011). Telomerase: An RNP enzyme synthesizes DNA. Cold Spring Harbor Perspectives in Biology, 3, 1–9. doi: 10.1101/cshperspect.a003558.
   Google Scholar
• Bower, J.E., Ganz, P.A., Dickerson, S.S., Petersen, L., Aziz, N. & Fahey, J.L. (2005). Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology, 30, 92–100.
   PubMed Web of Science ®Google Scholar
• Bukberg, J., Penman, D. & Holland, J.C. (1984). Depression in hospitalized cancer patients. Psychosomatic Medicine, 46, 199–212.
   PubMed Web of Science ®Google Scholar
• Capuron, L., Ravaud, A., Gualde, N., Bosmans, E., Dantzer, R., Maes, M. & Neveu, P.J. (2001). Association between immune activation and early depressive symptoms in cancer patients treated with interleukin-2-based therapy. Psychoneuroendocrinology, 26, 797–808.
   PubMed Web of Science ®Google Scholar
• Carlson, L.E., Doll, R., Stephen, J., Faris, P., Tamagawa, R., Drysdale, E. & Speca, M. (2013). Randomized controlled trial of mindfulness-based cancer recovery versus supportive expressive group therapy for distressed survivors of breast cancer (MINDSET). Journal of Clinical Oncology, 31, 3119–3126.
   PubMed Web of Science ®Google Scholar
• Carlson, L.E. & Garland, S.N. (2005). Impact of mindfulness-based stress reduction (MBSR) on sleep, mood, stress and fatigue symptoms in cancer outpatients. International Journal of Behavioral Medicine, 12, 278–285.
   PubMed Web of Science ®Google Scholar
• Carlson, L.E., Speca, M., Patel, K.D. & Goodey, E. (2003). Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress, and immune parameters in breast and prostate cancer outpatients. Psychosomatic Medicine, 65, 571–581.
   PubMed Web of Science ®Google Scholar
• Carlson, L.E., Speca, M., Patel, K.D. & Goodey, E. (2004). Mindfulness-based stress reduction in relation to quality of life, mood, symptoms of stress and levels of cortisol, dehydroepiandrosterone sulfate (DHEAS) and melatonin in breast and prostate cancer outpatients. Psychoneuroendocrinology, 29, 448–474.
   PubMed Web of Science ®Google Scholar
• Caspi, A., Sugden, K., Moffitt, T.E., Taylor, A., Craig, I.W., Harrington, H., … Poulton, R. (2003). Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene. Science, 301, 386–389.
   PubMed Web of Science ®Google Scholar
• Ciaramella, A. & Poli, P. (2001). Assessment of depression among cancer patients: The role of pain, cancer type and treatment. Psycho-Oncology, 10, 156–165.
   PubMed Web of Science ®Google Scholar
• Classen, C.C. & Spiegel, D. (2011). Supportive Expressive Group Psychotherapy. Handbook of Psychotherapy in Cancer Care. Chichester: Wiley.
   Google Scholar
• Cleeland, C.S., Bennett, G.J., Dantzer, R., Dougherty, P.M., Dunn, A.J., Meyers, C.A., … Lee, B.N. (2003). Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer, 97, 2919–2925.
   PubMed Web of Science ®Google Scholar
• Cohen, L., Cole, S.W., Sood, A.K., Prinsloo, S., Kirschbaum, C., Arevalo, J.M., … Pisters, L. (2012). Depressive symptoms and cortisol rhythmicity predict survival in patients with renal cell carcinoma: Role of inflammatory signaling. PLOS ONE, 7, e42324.
   Web of Science ®Google Scholar
• Colleoni, M., Mandala, M., Peruzzotti, G., Robertson, C., Bredart, A. & Goldhirsch, A. (2000). Depression and degree of acceptance of adjuvant cytotoxic drugs. Lancet, 356, 1326–1327.
   PubMed Web of Science ®Google Scholar
• Coussens, L.M. & Werb, Z. (2002). Inflammation and cancer. Nature, 420, 860–867.
   PubMed Web of Science ®Google Scholar
• Currier, M.B. & Nemeroff, C.B. (2013). Depression as a risk factor for cancer: From pathophysiological advances to treatment implications. Annual Review of Medicine, 65, 9.1–9.19.
   Google Scholar
• Dantzer, R., O’Connor, J.C., Freund, G.G., Johnson, R.W. & Kelley, K.W. (2008). From inflammation to sickness and depression: When the immune system subjugates the brain. Nature Reviews Neuroscience, 9, 46–56.
   PubMed Web of Science ®Google Scholar
• Davies, C., Godwin, J., Gray, R., Clarke, M., Cutter, D., Darby, S., … Peto, R. (2011). Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: Patient-level meta-analysis of randomised trials. Lancet, 378, 771–784.
   PubMed Web of Science ®Google Scholar
• De Couck, M., Mravec, B. & Gidron, Y. (2012). You may need the vagus nerve to understand pathophysiology and to treat diseases. Clinical Science, 122, 323–328.
   Google Scholar
• Dhabhar, F.S., Burke, H.M., Epel, E.S., Mellon, S.H., Rosser, R., Reus, V.I. & Wolkowitz, O.M. (2009). Low serum IL-10 concentrations and loss of regulatory association between IL-6 and IL-10 in adults with major depression. Journal of Psychiatric Research, 43, 962–969.
   PubMed Web of Science ®Google Scholar
• Diaz-Montero, C.M., Salem, M.L., Nishimura, M.I., Garrett-Mayer, E., Cole, D.J. & Montero, A.J. (2009). Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy. Cancer Immunology & Immunotherapy, 58, 49–59.
   PubMed Web of Science ®Google Scholar
• Epel, E.S., Blackburn, E.H., Lin, J., Dhabhar, F.S., Adler, N.E., Morrow, J.D. & Cawthon, R.M. (2004). Accelerated telomere shortening in response to life stress. Proceedings of the National Academy of Science of the United States of America, 101, 17312–17315.
   Google Scholar
• Evans, D.L., Staab, J.P., Petitto, J.M., Morrison, M.F., Szuba, M.P., Ward, H.E., … O’Reardon, J.P. (1999). Depression in the medical setting: Biopsychological interactions and treatment considerations. Journal of Clinical Psychiatry, 60, 40–55.
   PubMedGoogle Scholar
• Faller, H., Bülzebruck, H., Drings, P. & Lang, H. (1999). Coping, distress, and survival among patients with lung cancer. Archives of General Psychiatry, 56, 756–762.
   PubMed Web of Science ®Google Scholar
• Fawzy, F.I., Cousins, N., Fawzy, N.W., Kemeny, M.E. Elashoff, R. & Morton, D. (1990). A structured psychiatric intervention for cancer patients: I. Changes over time in methods of coping and affective disturbance. Archives of General Psychiatry, 47, 720–725.
   PubMed Web of Science ®Google Scholar
• Fawzy, F.I., Fawzy, N.W., Hyun, C.S., Elashoff, R., Guthrie, D., Fahey, J.L. & Morton, D.L. (1993). Malignant melanoma: Effects of an early structural psychiatric intervention, coping and affective state on recurrence and survival 6 years later. Archives of General Psychiatry, 50, 681–689.
   PubMed Web of Science ®Google Scholar
• Feng, Z., Liu, L., Zhang, C., Zheng, T., Wang, J., Lin, M., … Hu, W. (2012). Chronic restraint stress attenuates p53 function and promotes tumorigenesis. Proceedings of the National Academy of Science of the United States of America, 109, 7013–7018.
   Google Scholar
• Fidler, I.J. (2003). The pathogenesis of cancer metastasis: The ‘seed and soil’ hypothesis revisited. Nature Reviews Cancer, 3, 453–458.
   PubMed Web of Science ®Google Scholar
• Fredericks, C.A., Drabant, E.M., Edge, M.D., Tillie, J.M., Hallmayer, J., Ramel, W., … Dhabhar, F.S. (2009). Healthy young women with serotonin transporter SS polymorphism show a pro-inflammatory bias under resting and stress conditions. Brain Behavior and Immunity, 24, 350–357.
   PubMedGoogle Scholar
• Gabrilovich, D.I. & Nagaraj, S. (2009). Myeloid-derived suppressor cells as regulators of the immune system. Nature Reviews: Immunology, 9, 162–174.
   PubMed Web of Science ®Google Scholar
• Gidron, Y., Perry, H. & Glennie, M. (2005). Does the vagus nerve inform the brain about preclinical tumours and modulate them?Lancet Oncology, 6, 245–248.
   PubMed Web of Science ®Google Scholar
• Gidron, Y. & Ronson, A. (2008). Psychosocial factors, biological mediators, and cancer prognosis: A new look at an old story. Current Opinion in Oncology, 20, 386–392.
   PubMed Web of Science ®Google Scholar
• Giese-Davis, J., Collie, K., Rancourt, K.M., Neri, E., Kraemer, H.C. & Spiegel, D. (2011). Decrease in depression symptoms is associated with longer survival in patients with metastatic breast cancer: A secondary analysis. Journal of Clinical Oncology, 29, 413–420.
   PubMed Web of Science ®Google Scholar
• Giese-Davis, J., Wilhelm, F.H., Conrad, A., Abercrombie, H.C., Sephton, S., Yutsis, M., … Spiegel, D. (2006). Depression and stress reactivity in metastatic breast cancer. Psychosomatic Medicine, 68, 675–683.
   PubMed Web of Science ®Google Scholar
• Golan, H., Kennedy, J.A., Frenkel, A., Parmet, Y., Feintuch, A., Levi, O. & Gidron, Y. (2009). Brain mapping of patients with lung cancer and controls: Inquiry into tumor-to-brain communication. Journal of nuclear medicine, 50, 1072–1075.
   PubMedGoogle Scholar
• Goodwin, P.J., Leszcz, M., Ennis, M., Koopmans, J., Vincent, L., Guther, H., Drysdale, E., … Hunter, J. (2001). The effect of group psychosocial support on survival in metastatic breast cancer. New England Journal of Medicine, 345, 1719–1726.
   PubMed Web of Science ®Google Scholar
• Grassi, L., Indelli, M., Marzola, M., Maestri, A., Santini, A., Piva, E. & Boccalon, M. (1996). Depressive symptoms and quality of life in home-care-assisted cancer patients. Journal of Pain and Symptom Management, 12, 300–307.
   PubMed Web of Science ®Google Scholar
• Gu, J., Chen, M., Shete, S., Amos, C.I., Kamat, A., Ye, Y., … Wu, X. (2011). A genome-wide association study identifies a locus on chromosome 14q21 as a predictor of leukocyte telomere length and as a marker of susceptibility for bladder cancer. Cancer Prevention Research, 4, 514–521.
   PubMed Web of Science ®Google Scholar
• Guo, Y., Musselman, D.L., Manatunga, A., Gilles, N., Porter, M.R., McDaniel, S. & Nemeroff, C.B. (2006). The diagnosis of major depression in patients with cancer: A comparative approach. Psychosomatics, 47, 376–384.
   PubMedGoogle Scholar
• Heaphy, C.M., Subhawong, A.P., Gross, A.L., Konishi, Y., Kouprina, N., Argani, P., … Meeker, A.K. (2011). Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes. Modern Pathology, 24, 194–200.
   PubMedGoogle Scholar
• Henriksson, M.M., Isometsä, E.T., Hietanen, P.S., Aro, H.M. & Lönnqvist, J.K. (1995). Mental disorders in cancer suicides. Journal of Affective Disorders, 36, 11–20.
   PubMed Web of Science ®Google Scholar
• Horne, D. & Watson, M. (2011). Cognitive-behavioral therapies in cancer care. In D.W. Kissane & M. Watson (Eds), Handbook of Psychotherapy in Cancer Care (15–26). Chichester: Wiley.
   Google Scholar
• Jacobs, T.L., Epel, E.S., Lin, J., Blackburn, E.H., Wolkowitz, O.M., Bridwell, D.A., … Saron, C.D. (2011). Intensive meditation training, immune cell telomerase activity, and psychological mediators. Psychoneuroendocrinology, 36, 664–681.
   PubMed Web of Science ®Google Scholar
• Kessler, R.C., McGonagle, K.A., Nelson, C.B., Hughes, M., Swartz, M. & Blazer, D.G. (1994). Sex and depression in the National Comorbidity Survey II: Cohort effects. Journal of Affective Disorders, 30, 15–26.
   PubMed Web of Science ®Google Scholar
• Kissane, D.W., Bloch, S., Miach, P., Smith, G.C., Seddon, A. & Keks, N. (1997). Cognitive-existential group therapy for patients with primary breast cancer – Techniques and themes. Psycho-Oncology, 6, 25–33.
   PubMed Web of Science ®Google Scholar
• Kissane, D.W., Grabsch, B., Clarke, D.M., Smith, G.C., Love, A.W., Bloch, S., … Li, Y. (2007). Supportive-expressive group therapy for women with metastatic breast cancer: Survival and psychosocial outcome from a randomized controlled trial. Psycho-Oncology, 16, 277–286.
   PubMed Web of Science ®Google Scholar
• Kissane, D.W., Love, A., Hatton, A., Bloch, S., Smith, G., Clarke, D.M., … Snyder, R.D. (2004). Effect of cognitive- existential group therapy on survival in early-stage breast cancer. Journal of Clinical Oncology, 22, 4255–4260.
   PubMed Web of Science ®Google Scholar
• Koenig, H.G., Meador, K.G., Cohen, H.J. & Blazer, D.G. (1992). Screening for depression in hospitalized elderly medical patients: Taking a closer look. Journal of the American Geriatrics Society, 40, 1013–1017.
   PubMed Web of Science ®Google Scholar
• Kuchler, T., Bestmann, B., Rappat, S., Henne-Bruns, D. & Wood-Dauphinee, S. (2007). Impact of psychotherapeutic support for patients with gastrointestinal cancer undergoing surgery: 10-year survival results of a randomized trial. Journal of Clinical Oncology, 25, 2702–2708.
   PubMedGoogle Scholar
• Kuchler, T., Henne-Bruns, D., Rappat, S., Graul, J., Holst, K., Williams, J.I. & Wood-Dauphinee, S. (1999). Impact of psychotherapeutic support on gastrointestinal cancer patients undergoing surgery: Survival results of a trial. Hepato-Gastroenterology, 46, 322–335.
   PubMed Web of Science ®Google Scholar
• Kugaya, A., Akechi, T., Okuyama, T., Nakano, T., Mikami, I., Okamura, H. & Uchitomi, Y. (2000). Prevalence, predictive factors, and screening for psychologic distress in patients with newly diagnosed head and neck cancer. Cancer, 88, 2817–2823.
   PubMed Web of Science ®Google Scholar
• Landen, C.N. Jr, Lin, Y.G., Armaiz Pena, G.N., Das, P.D., Arevalo, J.M., Kamat, A.A., … Sood, A.K. (2007). Neuroendocrine modulation of signal transducer and activator of transcription-3 in ovarian cancer. Cancer Research, 67, 10389–10396.
   PubMed Web of Science ®Google Scholar
• Ledenberg, S. & Holland, J. (2011). Supportive psychotherapy in cancer care: An essential ingredient of all therapy. In D.W. Kissane & M. Watson (Eds), Handbook of Psychotherapy in Cancer Care (1–14). Chichester: Wiley.
   Google Scholar
• Levy, S., Herberman, R., Lippman, M. & D’Angelo, T. (1987). Correlation of stress factors with sustained depression of natural killer cell activity and predicted prognosis in patients with breast cancer. Journal of Clinical Oncology, 5, 348–353.
   PubMed Web of Science ®Google Scholar
• Levy, S.M., Herberman, R.B., Lippman, M., D’Angelo, T. & Lee, J. (1991). Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behavioral Medicine, 17, 67–75.
   PubMed Web of Science ®Google Scholar
• Levy, S.M., Herberman, R.B., Maluish, A.M., Schlien, B. & Lippman, M. (1985). Prognostic risk assessment in primary breast cancer by behavioral and immunological parameters. Health Psychology, 4, 99–113.
   PubMed Web of Science ®Google Scholar
• Li, M., Boquiren, V., Lo, C. & Rodin, G. (2011). Depression and anxiety in supportive oncology. In M.P. Davis, P.C. Feyer, P. Ortner & C. Zimmerman (Eds), Supportive Oncology (pp. 528–540). Philadelphia, PA: Elsevier.
   Google Scholar
• Lillberg, K., Verkasalo, P.K., Kaprio, J., Teppo, L., Helenius, H. & Koskenvuo, M., (2003). Stressful life events and risk of breast cancer in 10,808 women: A cohort study. American Journal of Epidemiology, 157, 415–423.
   PubMed Web of Science ®Google Scholar
• Loprinzi, C.L., Kugler, J.W., Sloan, J.A., Mailliard, J.A., LaVasseur, B.I., Barton, D.L., … Christensen, B.J. (2000). Venlafaxine in management of hot flashes in survivors of breast cancer: A randomised controlled trial. Lancet, 356, 2059–2063.
   PubMed Web of Science ®Google Scholar
• Loprinzi, C.L., Sloan, J.A., Perez, E.A., Quella, S.K., Stella, P.J., Mailliard, J.A., … Rummans, T.A. (2002). Phase III: Evaluation of fluoxetine for treatment of hot flashes. Journal of Clinical Oncology, 20, 1578–1583.
   PubMed Web of Science ®Google Scholar
• Lutgendorf, S.K., DeGeest, K., Dahmoush, L., Farley, D., Penedo, F., Bender, D., … Cole, S.W. (2011). Social isolation is associated with elevated tumor norepinephrine in ovarian carcinoma patients. Brain Behavior and Immunity, 25, 250–255.
   PubMed Web of Science ®Google Scholar
• Lutgendorf, S.K., Sood, A.K. & Antoni, M.H. (2010). Host factors and cancer progression: biobehavioral signaling pathways and interventions. Journal of Clinical Oncology, 28, 4094–4099.
   PubMed Web of Science ®Google Scholar
• Max, M.B., Lynch, S.A., Muir, J., Shoaf, S.E., Smoller, B. & Dubner, R. (1992). Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy. New England Journal of Medicine, 326, 1250–1256.
   PubMed Web of Science ®Google Scholar
• Massie, M.J. (2004). Prevalence of depression in patients with cancer. Journal of the National Cancer Institute, 32, 57–71.
   Google Scholar
• McDaniel, J.S., Musselman, D.L., Porter, M.R., Reed, D.A. & Nemeroff, C.B. (1995). Depression in patients with cancer. Diagnosis, biology, and treatment. Archives of General Psychiatry, 52, 89–99.
   PubMed Web of Science ®Google Scholar
• McDaniel, J.S., Musselman, D.L. & Nemeroff, C.B. (1997). Cancer and depression: Theory and treatment. Psychiatric Annals, 27, 360–364.
   Web of Science ®Google Scholar
• McEwen, B. S. (1998). Protective and damaging effects of stress mediators. New England Journal of Medicine, 338, 171–179.
   PubMed Web of Science ®Google Scholar
• Miller, A.H., Ancoli-Israel, S., Bower, J.E., Capuron, L. & Irwin, M.R. (2008). Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer. Journal of Clinical Oncology, 26, 971–982.
   PubMed Web of Science ®Google Scholar
• Miller, S., Lo, C., Gagliese, L., Hales, S., Rydall, A., Zimmermann, C., … Rodin, G. (2011). Patterns of depression in cancer patients: An indirect test of gender-specific vulnerabilities to depression. Social Psychiatry and Psychiatric Epidemiology, 46, 767–774.
   PubMed Web of Science ®Google Scholar
• Misono, S., Weiss, N.S., Fann, J.R., Redman, M. & Yueh, B. (2008). Incidence of suicide in persons with cancer. Journal of Clinical Oncology, 26, 4731–4738.
   PubMed Web of Science ®Google Scholar
• Mitchell, A.J., Chan, M., Bhatti, H., Halton, M., Grassi, L., Johansen, C. & Meader, N. (2011). Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. Lancet Oncology, 12, 160–174.
   PubMed Web of Science ®Google Scholar
• Mravec, B., Gidron, Y. & Hulin, I. (2008). Neurobiology of cancer: Interactions between nervous, endocrine and immune systems as a base for monitoring and modulating the tumorigenesis by the brain. Seminars in Cancer Biology, 18, 150–163.
   PubMedGoogle Scholar
• Mravec, B., Gidron, Y., Kukanova, B., Bizik, J., Kiss, A. & Hulin, I. (2006). Neural-endocrine-immune complex in the central modulation of tumorigenesis: Facts, assumptions, and hypotheses. Journal of Neuroimmunology, 180, 104–116.
   PubMedGoogle Scholar
• Mravec, B. & Hulin, I. (2006). Does vagus nerve constitute a self-organization complexity or a hidden network?Bratislavske Lekarske Listy, 107, 3–8.
   PubMedGoogle Scholar
• Mravec, B., Lackovicova, L., Pirnik, Z., Bizik, J., Bundzikova, J., Hulin, I. & Kiss, A. (2009). Brain response to induced peripheral cancer development in rats: Dual fos-tyrosine hydroxylase and fos-oxytocin immunohistochemistry. Endocrine regulations, 43, 3–11.
   PubMedGoogle Scholar
• Musselman, D.L., McDaniel, J.S., Anderson, G., Porter, M.F. & Nemeroff, C.B. (1996). Depression in patients with cancer. Directions in Psychiatry, 16, 1–11.
   Google Scholar
• Musselman, D.L., McDaniel, J.S., Porter, M.R. & Nemeroff, C.B. (1998). Psychoneuroendocrinology and Cancer. In J. Holland (Ed.), Psycho-oncology (pp. 135–143). New York: Oxford University Press.
   Google Scholar
• Musselman, D.L., Lawson, D.H., Gumnick, J.F., Manatunga, A.K., Penna, S., Goodkin, R.S., … Miller, A.H. (2001a). Paroxetine for the prevention of depression induced by high-dose interferon alfa. New England Journal of Medicine, 344, 961–966.
   PubMed Web of Science ®Google Scholar
• Musselman, D.L., Miller, A.H., Porter, M.R., Manatunga, A., Gao, F., Penna, S., … Nemeroff, C.B. (2001b). Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: Preliminary findings. American Journal of Psychiatry, 158, 1252–1257.
   PubMed Web of Science ®Google Scholar
• Newport, D.J. & Nemeroff, C.B. (1998). Assessment and treatment of depression in the cancer patient. Journal of Psychosomatic Research, 45, 215–237.
   PubMed Web of Science ®Google Scholar
• Newport, D.J. & Nemeroff, C.B. (1999). Treatment of depression in the cancer patient. Clinical Geriatrics, 7, 40–55.
   Google Scholar
• O’Hara, R., Luzon, A., Hubbard, J. & Zeitzer, J.M. (2009). Sleep apnea, apolipoprotein epsilon 4 allele, and TBI: mechanism for cognitive dysfunction and development of dementia. Journal of Rehabilitation Research and Development, 46, 837–850.
   PubMedGoogle Scholar
• O’Hara, R., Schröder, C.M., Mahadevan, R., Schatzberg, A.F., Lindley, S., Fox, S., … Hallmayer, J.F. (2007). Serotonin transporter polymorphism, memory and hippocampal volume in the elderly: Association and interaction with cortisol. Molecular Psychiatry, 12, 544–555.
   PubMed Web of Science ®Google Scholar
• O’Hara, R., Sommer, B., Way, N., Kraemer, H.C., Taylor, J. & Murphy, G. (2008). Slower speed-of-processing of cognitive tasks is associated with presence of the apolipoprotein epsilon4 allele. Journal of Psychiatric Research, 42, 199–204.
   PubMedGoogle Scholar
• Okamura, H., Watanabe, T., Narabayashi, M., Katsumata, N., Ando, M., Adachi, I., … Uchitomi, Y. (2000). Psychological distress following first recurrence of disease in patients with breast cancer: Prevalence and risk factors. Breast Cancer Research and Treatment, 61, 131–137.
   PubMed Web of Science ®Google Scholar
• Olofsson, P.S., Katz, D.A., Rosas-Ballina, M., Levine, Y.A., Ochani, M., Valdés-Ferrer, S.I., … Chavan, S.S. (2012). Alpha7 nicotinic acetylcholine receptor (alpha7nAChR) expression in bone marrow-derived non-T cells is required for the inflammatory reflex. Molecular Medicine, 18, 539–543.
   PubMed Web of Science ®Google Scholar
• Ostrand-Rosenberg & Sinha, P. (2009). Myeloid-derived suppressor cells: Linking inflammation and cancer. Journal of Immunology, 182, 4499–4506.
   PubMed Web of Science ®Google Scholar
• Peto, R., Boreham, J., Clarke, M., Davies, C. & Beral, V. (2000). UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years. Lancet, 355, 1822.
   PubMed Web of Science ®Google Scholar
• Pires, M.M., Hopkins, B.D., Saal, L.H. & Parsons, R.E. (2013). Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells. Cancer Biology Therapy, 14, 246–253.
   PubMed Web of Science ®Google Scholar
• Pooley, K.A., Sandhu, M.S., Tyrer, J., Shah, M., Driver, K.E., Luben, R.N., … Dunning, A.M. (2010). Telomere length in prospective and retrospective cancer case-control studies. Cancer Research, 70, 3170–3176.
   PubMedGoogle Scholar
• Powell, N.D., Tarr, A.J. & Sheridan, J.F. (2013). Psychosocial stress and inflammation in cancer. Brain, behavior, and immunity, 30, S41–47.
   PubMed Web of Science ®Google Scholar
• Prieto, J.M., Blanch, J., Atala, J., Carreras, E., Rovira, M., Cirera, E. & Gastó, C. (2002). Psychiatric morbidity and impact on hospital length of stay among hematologic cancer patients receiving stem-cell transplantation. Journal of Clinical Oncology, 20, 1907–1917.
   PubMed Web of Science ®Google Scholar
• Raison, C.L. & Miller, A.H. (2003). Depression in cancer: New developments regarding diagnosis and treatment. Biological Psychiatry, 54, 283–294.
   PubMed Web of Science ®Google Scholar
• Raison, C.L. & Nemeroff, C.B. (2000). Cancer and depression: Prevalence, diagnosis, and treatment. Home Healthcare Consultant, 7, 34–41.
   Google Scholar
• Roscoe, J.A., Morrow, G.R., Hickok, J.T., Mustian, K.M., Griggs, J.J., Matteson, S.E., … Smith, B. (2005). Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy. Breast Cancer Research and Treatment, 89, 243–249.
   PubMed Web of Science ®Google Scholar
• Ross, L., Boesen, E.H., Dalton, S.O. & Johansen, C. (2002). Mind and cancer: Does psychosocial intervention improve survival and psychological well-being?European Journal of Cancer, 38, 1447–1457.
   PubMed Web of Science ®Google Scholar
• Rutter, P.A., Freedenthal, S. & Osman, A. (2008). Assessing protection from suicidal risk: Psychometric properties of the suicide resilience inventory. Death Studies, 32, 142–153.
   PubMed Web of Science ®Google Scholar
• Satin, J.R., Linden, W. & Phillips, M.J. (2009). Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis. Cancer, 115, 5349–5361.
   PubMed Web of Science ®Google Scholar
• Schiepers, O.J., Wichers, M.C. & Maes, M. (2005). Cytokines and major depression. Progress in Neuro-psychopharmacology and Biological Psychiatry, 29, 201–217.
   PubMed Web of Science ®Google Scholar
• Seeman, T.E. & McEwen, B.S. (1996). Impact of social environment characteristics on neuroendocrine regulation. Psychosomatic Medicine, 58, 459–471.
   PubMed Web of Science ®Google Scholar
• Semenchuk, M.R., Sherman, S. & Davis, B. (2001). Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain. Neurology, 57, 1583–1588.
   PubMed Web of Science ®Google Scholar
• Sephton, S. & Spiegel, D. (2003). Circadian disruption in cancer: A neuroendocrine-immune pathway from stress to disease?Brain Behavior and Immunity, 17, 321–328.
   PubMed Web of Science ®Google Scholar
• Sephton, S.E., Dhabhar, F.S., Keuroghlian, A.S., Giese-Davis, J., McEwen, B.S., Ionan, A.C. & Spiegel, D. (2009). Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer. Brain Behavior and Immunity, 23, 1148–1155.
   PubMed Web of Science ®Google Scholar
• Sephton, S.E., Lush, E., Dedert, E.A., Floyd, A.R., Rebholz, W.N., Dhabhar, F.S., … Salmon, P. (2013). Diurnal cortisol rhythm as a predictor of lung cancer survival. Brain Behavior and Immunity, 30, S163–170.
   PubMed Web of Science ®Google Scholar
• Sephton, S.E., Sapolsky, R.M., Kraemer, H.C. & Spiegel, D. (2000). Diurnal cortisol rhythm as a predictor of breast cancer survival. Journal of the National Cancer Institute, 92, 994–1000.
   PubMed Web of Science ®Google Scholar
• Seruga, B., Zhang, H., Bernstein, L.J. & Tannock, I.F. (2008). Cytokines and their relationship to the symptoms and outcome of cancer. Nature Reviews Cancer, 8, 887–899.
   PubMed Web of Science ®Google Scholar
• Shen, J., Gammon, M.D., Terry, M.B., Wang, Q., Bradshaw, P., Teitelbaum, S.L., … Santella, R.M. (2009). Telomere length, oxidative damage, antioxidants and breast cancer risk. International Journal of Cancer, 124, 1637–1643.
   PubMedGoogle Scholar
• Shen, J., Terry, M.B., Gurvich, I., Liao, Y., Senie, R.T. & Santella, R.M. (2007). Short telomere length and breast cancer risk: A study in sister sets. Cancer Research, 67, 5538–5544.
   PubMed Web of Science ®Google Scholar
• Solito, S., Falisi, E., Diaz-Montero, C.M., Doni, A., Pinton, L. & Rosato, A. (2011). A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood, 118, 2254–2265.
   PubMed Web of Science ®Google Scholar
• Sood, A.K., Armaiz-Pena, G.N., Halder, J., Nick, A.M., Stone, R.L., Hu,W., … Lutgendorf, S.K. (2010). Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis. Journal of Clinical Investigation, 120, 1515–1523.
   PubMed Web of Science ®Google Scholar
• Spannuth, W.A., Sood, A.K. & Coleman, R.L. (2008). Angiogenesis as a strategic target for ovarian cancer therapy. Nature Clinical Practice Oncology, 5, 194–204.
   PubMedGoogle Scholar
• Spiegel, D. (2002). Effects of psychotherapy on cancer survival. Nature Reviews Cancer, 2, 383–389.
   PubMed Web of Science ®Google Scholar
• Spiegel, D. (2011). Mind matters in cancer survival. Journal of the American Medical Association, 305, 502–503.
   PubMed Web of Science ®Google Scholar
• Spiegel, D. (2013). Minding the body: Psychotherapy and cancer survival. British Journal of Health Psychology. doi: 10.1111/bjhp.12061
   PubMedGoogle Scholar
• Spiegel, D., Bloom, J.R., Kraemer, H.C. & Gottheil, E. (1989). Effect of psychosocial treatment on survival of patients with metastatic breast cancer. Lancet, 2, 888–891.
   PubMed Web of Science ®Google Scholar
• Spiegel, D., Bloom, J.R. & Yalom, I. (1981). Group support for patients with metastatic cancer. A randomized outcome study. Archives of General Psychiatry, 38, 527–533.
   PubMed Web of Science ®Google Scholar
• Spiegel, D., Butler, L.D., Giese-Davis, J., Koopman, C., Miller, E., DiMiceli, S., … Kraemer, H.C. (2007). Effects of supportive-expressive group therapy on survival of patients with metastatic breast cancer: A randomized prospective trial. Cancer, 110, 1130–1138.
   PubMed Web of Science ®Google Scholar
• Spiegel, D. & Classen, C. (2000). Group Therapy for Cancer Patients: A Research-Based Handbook of Psychosocial Care. New York, Basic Books.
   Google Scholar
• Spiegel, D. & Giese-Davis, J. (2003). Depression and cancer: Mechanisms and disease progression. Biological Psychiatry, 54, 269–282.
   PubMed Web of Science ®Google Scholar
• Stearns, V., Isaacs, C., Rowland, J., Crawford, J., Ellis, M.J., Kramer, R., … Hayes, D.F. (2000). A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil®) in controlling hot flashes in breast cancer survivors. Annals of Oncology, 11, 17–22.
   PubMed Web of Science ®Google Scholar
• Stommel, M., Given, B.A. & Given, C.W. (2002). Depression and functional status as predictors of death among cancer patients. Cancer, 94, 2719–2727.
   PubMed Web of Science ®Google Scholar
• Sumpton, J.E. & Moulin, D.E. (2001). Treatment of neuropathic pain with venlafaxine. Annals of Pharmacotherapy, 35, 557–559.
   PubMed Web of Science ®Google Scholar
• Svenson, U., Ljungberg, B. & Roos, G. (2009). Telomere length in peripheral blood predicts survival in clear cell renal cell carcinoma. Cancer Research, 69, 2896–2901.
   PubMed Web of Science ®Google Scholar
• Temel, J.S., Greer, J.A., Muzikansky, A., Gallagher, E.R., Admane, S., Jackson, V.A., … Lynch, T.J. (2010). Early palliative care for patients with metastatic non-small-cell lung cancer. New England Journal of Medicine, 363, 733–742.
   PubMed Web of Science ®Google Scholar
• Thaker, P.H., Han, L.Y., Kamat, A.A., Arevalo, J.M., Takahashi, R., Lu, C., … Sood, A.K. (2006). Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nature Medicine, 12, 939–944.
   PubMed Web of Science ®Google Scholar
• Waraich, P., Goldner, E., Somers, J. & Hsu, L. (2004). Prevalence and incidence studies of mood disorders: A systematic review of the literature. Canadian Journal of Psychiatry, 49, 124–138.
   PubMed Web of Science ®Google Scholar
• Watson, R.J.D. & Richardson, P.H. (1999). Identifying randomized controlled trials of cognitive therapy for depression: Comparing the efficiency of Embase, Medline, and PsycINFO bibliographic databases. British Journal of Medical Psychology, 72, 535–542.
   PubMedGoogle Scholar
• Weinrib, A.Z., Sephton, S.E., Degeest, K., Penedo, F., Bender, D., Zimmerman, B., … Lutgendorf, S.K. (2010). Diurnal cortisol dysregulation, functional disability, and depression in women with ovarian cancer. Cancer, 116, 4410–4419.
   PubMed Web of Science ®Google Scholar
• Wells, K.B., Stewart, A., Hays, R.D., Burnam, M.A., Rogers, W., Daniels, M., … Ware, J. (1989). The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. Journal of the American Medical Association, 262, 914–919.
   PubMed Web of Science ®Google Scholar
• Willeit, P., Willeit, J., Mayr, A., Weger, S., Oberhollenzer, F., Brandstätter, A., … Kiechl, S. (2010). Telomere length and risk of incident cancer and cancer mortality. Journal of the American Medical Association, 304, 69–75.
   PubMed Web of Science ®Google Scholar
• Williams, S. & Dale, J. (2006). The effectiveness of treatment for depression/depressive symptoms in adults with cancer: A systematic review. British Journal of Cancer, 94, 372–390.
   PubMed Web of Science ®Google Scholar
• Wu, X., Amos, C.I., Zhu, Y., Zhao, H., Grossman, B.H., Shay, J.W., … Spitz, M.R. (2003). Telomere dysfunction: A potential cancer predisposition factor. Journal of the National Cancer Institute, 95, 1211–1218.
   PubMed Web of Science ®Google Scholar
• Yu, J.L. & Rak, J.W. (2003). Host microenvironment in breast cancer development: Inflammatory and immune cells in tumour angiogenesis and arteriogenesis. Breast Cancer Research, 5, 83–88.
   PubMed Web of Science ®Google Scholar